Pregled bibliografske jedinice broj: 47015
Randomized double-blind, placebo-controllec study of azithromycin in C.Pneumoniae Positive Postmyocardial Infarction patients (CROAATS)
Randomized double-blind, placebo-controllec study of azithromycin in C.Pneumoniae Positive Postmyocardial Infarction patients (CROAATS) // Atherosclerosis (Amsterdam), 151 (2000) (podatak o recenziji nije dostupan, kongresno priopcenje, znanstveni)
CROSBI ID: 47015 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Randomized double-blind, placebo-controllec study of azithromycin in C.Pneumoniae Positive Postmyocardial Infarction patients (CROAATS)
Autori
Reiner, Ž. ; Bergovec, M. ; Gjurašin, M. ; Goldner, V. ; Halle, J. ; Kranjčević, S. ; Mihatov, Š. ; Zrnić, T. ; Čulig, J. ; Tedeschi-Reiner, E.
Izvornik
Atherosclerosis (Amsterdam) (0021-9150) 151
(2000);
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, kongresno priopcenje, znanstveni
Ključne riječi
Randomized double-blind; placebo-controllec study of azithromycin in C.Pneumoniae Positive Postmyocardial Infarction patients (CROAATS)
Sažetak
However, the observed distribuion of ACVE speaks in favor of the proposed hypothesis that Chlamidia pneumoniae positive patients have a higher risk of recurrent cardiovascular events.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- SCI-EXP, SSCI i/ili A&HCI